<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04883034</url>
  </required_header>
  <id_info>
    <org_study_id>ACB OUTPATIENT CLINIC</org_study_id>
    <nct_id>NCT04883034</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty</brief_title>
  <acronym>ACB</acronym>
  <official_title>Adductor Canal Block in Outpatient Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gadjah Mada University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gadjah Mada University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-shot Adductor Canal Block in the outpatient clinic is safe, significantly decreased&#xD;
      pain and analgesic consumption and may enhance the rehabilitation program&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ACB in the outpatient clinic is safe and can minimize postoperative pain. The primary&#xD;
      goal of this research was to see how ACB affected the Visual Analog Score (VAS) pain score&#xD;
      during the rehabilitation as opposed to controls. The secondary goal was to determine how&#xD;
      much analgesic (etoricoxibe) was consumed on a daily basis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog pain score (VAS)</measure>
    <time_frame>one month</time_frame>
    <description>A VAS scale was used to assess pain severity, with 0 indicating no pain and 10 indicating extreme pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic oral intake (etoricoxibe)</measure>
    <time_frame>one month</time_frame>
    <description>determine how much analgesic (etoricoxibe) was consumed on a daily basis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Pain</condition>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>pain management post total knee arthroplasty with analgetic oral</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients in control group were given analgesic (etoricoxibe) on a daily basis, with the option to increase the dose if pain persisted, up to a maximum of 120 mg per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pain management post total knee arthroplasty with adductor canal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On postoperative day 14 (POD 14), the ACB was performed for ACB group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>adductor canal block in outpatient clinic</intervention_name>
    <description>perform adductor canal block in outpatient clinic for patient post total knee arthroplasty</description>
    <arm_group_label>pain management post total knee arthroplasty with adductor canal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Analgesics, etoricoxibe</intervention_name>
    <description>anaelgetic oral intake</description>
    <arm_group_label>pain management post total knee arthroplasty with analgetic oral</arm_group_label>
    <other_name>etoricoxibe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indonesian or Javanese-speaking adults&#xD;
&#xD;
          -  After perfomed total knee replacement&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status I-III&#xD;
&#xD;
          -  body mass index (BMI) of 18-40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Declined to complete the study&#xD;
&#xD;
          -  Unable to cooperate&#xD;
&#xD;
          -  had an allergic reaction to any of the drugs&#xD;
&#xD;
          -  abusing alcohol or drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>sholahuddin rhatomy, dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gadjah Mada University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>sholahuddin rhatomy, Dr</last_name>
    <phone>+6281808720707</phone>
    <email>sholahuddin.rhatomy@ugm.ac.id</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sholahuddin Rhatomy</name>
      <address>
        <city>Sleman</city>
        <state>Yogyakarta</state>
        <zip>55281</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sholahuddin rhatomy, Dr</last_name>
      <phone>+6281808720707</phone>
      <email>sholahuddin.rhatomy@ugm.ac.id</email>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gadjah Mada University</investigator_affiliation>
    <investigator_full_name>Sholahuddin Rhatomy</investigator_full_name>
    <investigator_title>Head Of orthopaedic and Traumatology Department, Dr Soeradji Tirtonegoro Hospital/Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

